DEFLAZACORT

DEFDOZE / FRIZCORT 6

null
defdoze 30
defdoze 30
COMPOSITION
DEFLAZACORT6 MG 30 MG
SPECIFICATION
FORMTABLETTABLETPEDIATRIC
PACKING10X10 1X1030ml
PACKING TYPEALU ALUALU ALU–
MRP850 / 900480068

ALSO AVAILABLE

DESCRIPTION

Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant. It was approved in February, 2017 by the FDA for use in treatment of Duchenne muscular dystrophy (trade name Emflaza).

SIDE EFFECTS

The LD50 for the oral dose is greater than 4000 mg/kg in laboratory animals.

INDICATION

corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

Important Notice:-  The Database is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

null